Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Alejandro Piris Gimenez"'
Autor:
Manuela Monti, Tom Degenhardt, Etienne Brain, Rachel Wuerstlein, Alessandra Argusti, Matteo Puntoni, Gian Andrea Rollandi, Davide Corradengo, Luca Boni, Harun Ilhan, Oriana Nanni, Javier Cortes, Alejandro Piris-Gimenez, Arnoldo Piccardo, Massimiliano Iacozzi, Federica Matteucci, Valentina Di Iorio, Jean Louis Alberini, Carolien Schröder, Nadia Harbeck, Alessandra Gennari
Publikováno v:
Frontiers in Medicine, Vol 8 (2022)
Background: Academic research is important to face unmet medical needs. The Oncological community encounters many hurdles in setting up multicenter investigator-driven trials mainly due to administrative complexity. The purpose of a network organizat
Externí odkaz:
https://doaj.org/article/a08e1d94b5794d59b8d70e7dab7c78f2
Autor:
Elena Elez, Javier Ros, Jose Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Carlota Arenillas, Kinga Bernatowicz, Raquel Comas, Shanshan Li, David Philip Kodack, Roberta Fasani, Ariadna Garcia, Javier Gonzalo-Ruiz, Alejandro Piris-Gimenez, Paolo Nuciforo, Grainne Kerr, Rossana Intini, Aldo Montagna, Marco Maria Germani, Giovanni Randon, Ana Vivancos, Ron Smits, Diana Graus, Raquel Perez-Lopez, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Rodrigo Dienstmann, Josep Tabernero, Rodrigo A. Toledo
Publikováno v:
Scientia
Nature Medicine, 28(10), 2162-2170. Nature Publishing Group
Nature Medicine, 28(10), 2162-2170. Nature Publishing Group
Colorectal cancer; Predictive markers; Tumour biomarkers Cáncer colorrectal; Marcadores predictivos; Biomarcadores tumorales Càncer colorrectal; Marcadors predictius; Biomarcadors tumorals Anti-BRAF/EGFR therapy was recently approved for the treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1cfcc9244c422b74e6bbcfe10d9f95
https://hdl.handle.net/11351/8672
https://hdl.handle.net/11351/8672
Autor:
Elena, Elez, Javier, Ros, Jose, Fernández, Guillermo, Villacampa, Ana Belén, Moreno-Cárdenas, Carlota, Arenillas, Kinga, Bernatowicz, Raquel, Comas, Shanshan, Li, David Philip, Kodack, Roberta, Fasani, Ariadna, Garcia, Javier, Gonzalo-Ruiz, Alejandro, Piris-Gimenez, Paolo, Nuciforo, Grainne, Kerr, Rossana, Intini, Aldo, Montagna, Marco Maria, Germani, Giovanni, Randon, Ana, Vivancos, Ron, Smits, Diana, Graus, Raquel, Perez-Lopez, Chiara, Cremolini, Sara, Lonardi, Filippo, Pietrantonio, Rodrigo, Dienstmann, Josep, Tabernero, Rodrigo A, Toledo
Publikováno v:
Nature medicine. 28(10)
Anti-BRAF/EGFR therapy was recently approved for the treatment of metastatic BRAFsupV600E/supcolorectal cancer (mCRCsupBRAF-V600E/sup). However, a large fraction of patients do not respond, underscoring the need to identify molecular determinants of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f04136c084a308bf8c9f9b942f7330c0
https://pubmed.ncbi.nlm.nih.gov/36097219
https://pubmed.ncbi.nlm.nih.gov/36097219
Publikováno v:
PLoS Pathogens, Vol 3, Iss 6, p e76 (2007)
Bacillus anthracis causes three forms of anthrax: inhalational, gastrointestinal, and cutaneous. Anthrax is characterized by both toxemia, which is caused by secretion of immunomodulating toxins (lethal toxin and edema toxin), and septicemia, which i
Externí odkaz:
https://doaj.org/article/efbb4172ed4b4188a296385c18600f61
Autor:
Eleonora Leucci, Robert Clarke, Alejandro Piris Gimenez, Laura Soucek, Alberto Villanueva, Annette T. Byrne, Jos Jonkers, Leo S. Price, Hector G. Palmer, Sergio Roman-Roman, Luca Vezzadini, Zdenka Dudová, Terrence F. Meehan, Enzo Medico, Luisa Lanfrancone, Violeta Serra, Gunhild Mari Mælandsmo, Daniela Krasser, Didier Decaudin, Livio Trusolino, Ales Krenek, Marieke van de Ven, Andrea Wutte, Nathalie Conte, Francesca Sarno, Alejandra Bruna, Andrea Bertotti, Michaela Th. Mayrhofer, Steven de Jong, Emilie Vinolo, Jens Henrik Norum, Joaquín Arribas, Elisabetta Marangoni
Publikováno v:
Cancer Research. 80:1685-1685
Counteracting high failure rates in oncology drug development and improving therapeutic management of cancer patients requires preclinical models that can account for the complexity and heterogeneity of human tumors. Patient-derived cancer xenografts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2999d88b89618771ee78b5429f798477
https://doi.org/10.1158/1538-7445.am2020-1685
https://doi.org/10.1158/1538-7445.am2020-1685
Autor:
Marie Moya-Nilges, Jean-Philippe Corre, Michèle Mock, Jean-Claude Sirard, Agnès Fouet, Ian J. Glomski, Pierre L. Goossens, Alejandro Piris-Gimenez, Grégory Jouvion
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 207 (3), pp.450-7. ⟨10.1093/infdis/jis686⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 207 (3), pp.450-7. 〈10.1093/infdis/jis686〉
Journal of Infectious Diseases, 2013, 207 (3), pp.450-7. ⟨10.1093/infdis/jis686⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 207 (3), pp.450-7. ⟨10.1093/infdis/jis686⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2013, 207 (3), pp.450-7. 〈10.1093/infdis/jis686〉
Journal of Infectious Diseases, 2013, 207 (3), pp.450-7. ⟨10.1093/infdis/jis686⟩
International audience; BACKGROUND: Germination is a key step for successful Bacillus anthracis colonization and systemic dissemination. Few data are available on spore germination in vivo, and the necessity of spore and host cell interactions to ini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2e7e359bf96cd2115d05680aa89d7a0
https://www.hal.inserm.fr/inserm-00926617
https://www.hal.inserm.fr/inserm-00926617
Autor:
Grégory Jouvion, Jean-Philippe Corre, Thomas Candela, Pierre L. Goossens, Alejandro Piris-Gimenez, Huot Khun
Publikováno v:
Journal of Infectious Diseases
Journal of Infectious Diseases, Oxford University Press (OUP), 2009, 200 (9), pp.1381-9. ⟨10.1086/644506⟩
Journal of Infectious Diseases, 2009, 200 (9), pp.1381-9. ⟨10.1086/644506⟩
Journal of Infectious Diseases, Oxford University Press (OUP), 2009, 200 (9), pp.1381-9. ⟨10.1086/644506⟩
Journal of Infectious Diseases, 2009, 200 (9), pp.1381-9. ⟨10.1086/644506⟩
International audience; BACKGROUND: The Bacillus anthracis poly-gamma-D-glutamate capsule is essential for virulence. It impedes phagocytosis and protects bacilli from the immune system, thus promoting systemic dissemination. METHODS: To further defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f70957b3a636977974f72c721c646a7
https://hal-pasteur.archives-ouvertes.fr/pasteur-00512101/file/Piris-gimenez-JID.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-00512101/file/Piris-gimenez-JID.pdf
Publikováno v:
PLoS Pathogens
PLoS Pathogens, Vol 3, Iss 6, p e76 (2007)
PLoS Pathogens, Vol 3, Iss 6, p e76 (2007)
Bacillus anthracis causes three forms of anthrax: inhalational, gastrointestinal, and cutaneous. Anthrax is characterized by both toxemia, which is caused by secretion of immunomodulating toxins (lethal toxin and edema toxin), and septicemia, which i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1822df3849d342ea70ea7ca556c48d83
http://europepmc.org/articles/PMC1885272
http://europepmc.org/articles/PMC1885272
Autor:
Michel Chignard, Michèle Mock, Miguel Paya, Gérard Lambeau, Lhousseine Touqui, Alejandro Piris-Gimenez, Pierre L. Goossens
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2005, 175, pp.6786-6791. ⟨10.4049/jimmunol.175.10.6786⟩
Journal of Immunology, 2005, 175, pp.6786-6791. ⟨10.4049/jimmunol.175.10.6786⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2005, 175, pp.6786-6791. ⟨10.4049/jimmunol.175.10.6786⟩
Journal of Immunology, 2005, 175, pp.6786-6791. ⟨10.4049/jimmunol.175.10.6786⟩
Anthrax is an acute disease caused by Bacillus anthracis. Some animal species are relatively resistant to anthrax infection. This trait has been correlated to the extent of the local inflammatory reaction, suggesting innate immunity to be the first l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b22616e592fd97a316ce17548e43632
https://hal.archives-ouvertes.fr/hal-00083712
https://hal.archives-ouvertes.fr/hal-00083712
Autor:
Miguel Paya, Alejandro Piris Gimenez, Pierre L. Goossens, Yong-Zheng Wu, Lhousseine Touqui, Christophe Delclaux
Publikováno v:
Journal of Immunology
Journal of Immunology, 2004, 173 (1), pp.521-530. ⟨10.4049/jimmunol.173.1.521⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2004, 173 (1), pp.521-530. ⟨10.4049/jimmunol.173.1.521⟩
Journal of Immunology, 2004, 173 (1), pp.521-530. ⟨10.4049/jimmunol.173.1.521⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2004, 173 (1), pp.521-530. ⟨10.4049/jimmunol.173.1.521⟩
There is a considerable body of evidence supporting the role of secretory type II-A phospholipase A2 (sPLA2-IIA) as an effector of the innate immune response. This enzyme also exhibits bactericidal activity especially toward Gram-positive bacteria. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::769a242b135c21978636ceccd102732e
https://hal-pasteur.archives-ouvertes.fr/pasteur-02863055
https://hal-pasteur.archives-ouvertes.fr/pasteur-02863055